MICROBIOTICA
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and in vivo models.
MICROBIOTICA
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-12-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.microbiotica.com
Total Employee:
11+
Status:
Active
Contact:
+ 44 (0) 20 7866 7860
Email Addresses:
[email protected]
Total Funding:
62 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Current Advisors List
Current Employees Featured
Founder
Investors List
Seventure Partners
Seventure Partners investment in Series B - Microbiotica
British Patient Capital
British Patient Capital investment in Series B - Microbiotica
Flerie Invest
Flerie Invest investment in Series B - Microbiotica
IP Group
IP Group investment in Series B - Microbiotica
Tencent
Tencent investment in Series B - Microbiotica
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series B - Microbiotica
Seventure Partners
Seventure Partners investment in Venture Round - Microbiotica
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Seed Round - Microbiotica
IP Group
IP Group investment in Seed Round - Microbiotica
Official Site Inspections
http://www.microbiotica.com Semrush global rank: 3.81 M Semrush visits lastest month: 3.5 K
- Host name: box5716.bluehost.com
- IP address: 162.241.252.137
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Microbiotica"
Microbiotica – Precision Microbiome Medicines
Microbiotica is a clinic-ready biopharmaceutical company developing a pipeline of orally-delivered live biotherapeutic products (LBPs) composed of highly-defined bacterial strains for …See details»
About - Microbiotica
Microbiotica is a leading, clinical stage biopharmaceutical company specialising in the development of precision live biotherapeutic products (LBPs) with lead products in immuno …See details»
Platform – Microbiotica
Our platform, based on deep microbial culturing know-how, combines our leading gut bacterial reference genome database, which includes previously unidentified bacteria, a linked culture …See details»
Microbiotica - Crunchbase Company Profile & Funding
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. View contacts for Microbiotica to access new leads and connect with decision-makers.See details»
Microbiotica Company Profile 2024: Valuation, Funding
Operator of a biotechnology platform intended to discover and develop live bacterial therapeutics and biomarkers.See details»
Microbiotica - The Org
Transforming personalised medicine with leading microbiome science.See details»
Microbiotica—unlocking the microbiome as a multi …
Microbiotica’s platform makes it a leader in precision clinical discovery of novel microbiome-based therapeutics and biomarkers. With the platform validated at scale, and a pipeline of...See details»
Tim Sharpington - CEO at Microbiotica - The Org
Tim Sharpington is Chief Operating Officer of Microbiotica. He has established a track record of leading, developing, and executing company strategy, with experience in product …See details»
Management Team - Microbiotica
Adam Wilkinson is VP Pre-Clinical Development at Microbiotica. Adam is responsible for managing Pre-Clinical Development activities in the company including novel manufacturing and analytical technologies for Microbiotica’s …See details»
Microbiotica's Board of Directors - Team members and org chart
Microbiotica's Board of Directors includes Ciaran Kelly and 13 others.See details»
Microbiotica enters into microbiome collaboration with …
Nov 20, 2024 · Microbiotica, a leading player in microbiome-based therapeutics spun out of the Wellcome Sanger Institute, today announced that it has entered into a multi-year strategic collaboration with Genentech, a member of the …See details»
Translating precision in microbiome science into predictive …
Microbiotica is built on transformational advances of over a decade of research in Trevor Lawley’s Wellcome Sanger Institute laboratory that addressed key barriers, including the design of...See details»
Microbiotica appoints John Shields as non-executive director
May 12, 2017 · Microbiotica, the spin-out company from the UK’s Wellcome Trust Sanger Institute (Sanger Institute), is pleased to announce the appointment of Dr John Shields as a non …See details»
Microbiota in health and diseases - PMC - PubMed Central (PMC)
In this review, we discuss the current knowledge of how microbiota links to host health or pathogenesis. We first summarize the research of microbiota in healthy conditions, including …See details»
Microbiotica Receives Crohn’s & Colitis Foundation Funding to …
Cambridge, UK, 05 April 2022 – Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, today announces it has received project funding from the Crohn’s & Colitis …See details»
Early investments powering the ascent of microbiome therapeutics …
Nov 30, 2020 · Rebiotix and its parent company Ferring Pharmaceuticals announced positive preliminary phase 3 data from fecal microbial transplantation product RBX2660 in May, and …See details»
Microbiome definition re-visited: old concepts and new challenges
Jun 30, 2020 · We propose a definition of microbiome based on the compact, clear, and comprehensive description of the term provided by Whipps et al. in 1988, amended with a set …See details»
Microbiotica announces transition of leadership
Cambridge, UK, 29 November 2022 – Microbiotica, a leading player in discovering and developing microbiome-based therapeutics and biomarkers, announces a change of leadership as Mike …See details»
The function of our microbiota: who is out there and what do they …
In this review we will focus on our current understanding of the functionality of the human intestinal microbiota based on all available metagenome, metatranscriptome, and …See details»
Microbiotica Expands Management Team with Appointments of …
Cambridge, UK, 04 February 2021 – Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, today announces the appointment of Ronald Carter, MD, as …See details»